Streetbeat News

Earnings

TSLA

Tesla Inc (NASDAQ:TSLA) shares fell to a near-year low due to Cybertruck delivery delays and reports of workforce layoffs, including the departure of key executives Drew Baglino and Rohan Patel. The company faces weakening demand trends and is anticipated to report its first negative free cash flow quarter since 2020. Analysts expect EPS of 53 cents and revenue of $22.605 billion for the upcoming earnings, while GLJ Research analyst Gordon Johnson maintains a Sell rating, lowering the price target from $23.53 to $22.86.

Portfolio Pulse from Adam Eckert

April 16, 2024 | 7:09 pm

NFLX

Netflix Inc (NASDAQ:NFLX) is anticipated to report Q1 financial results on April 18, 2024, with expected revenue of $9.275 billion and EPS of $4.52, indicating growth from the previous year. Analysts highlight the potential for subscriber growth due to the ad-supported plan and crackdown on password sharing, with some predicting a price increase for subscriptions. Recent analyst ratings are generally positive, with several raising their price targets for NFLX. Key focuses for the upcoming report include subscriber numbers, potential price increases, and Netflix's sports content strategy.

Portfolio Pulse from Chris Katje

April 16, 2024 | 6:38 pm

APPN

Appian reports preliminary Q1 2024 revenue of $149.8M, surpassing estimates of $149.45M. Cloud subscription revenue is expected to be $86.6M, a 24% increase from Q1 2023. The company anticipates a GAAP net loss between $(33.9)M and $(32.4)M, an improvement from $(36.8)M in Q1 2023. Adjusted EBITDA loss is expected to narrow to between $(2.0)M and $(1.0)M from $(15.8)M in the previous year.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 6:37 pm

BNED

CLDI

PACB

WISA

U.S. stocks showed mixed performance with the S&P 500 dropping 0.3%, while the Dow edged up slightly and the NASDAQ fell. Notable movements included a plunge in Pacific Biosciences shares after weak guidance, a surge in WiSA Technologies shares following a licensing agreement announcement, and significant drops in Barnes & Noble Education and Calidi Biotherapeutics shares. Industrial production in the U.S. saw a 0.4% increase in March.

Portfolio Pulse from Avi Kapoor

April 16, 2024 | 6:30 pm

BNED

CLDI

SKIL

WISA

Skillsoft Corp. shares fell by 26.7% after reporting mixed Q4 results and lower-than-expected FY25 revenue guidance. Other stocks moved significantly in Tuesday's session, with notable gainers including WiSA Technologies and Palisade Bio, and losers like Barnes & Noble Education and Calidi Biotherapeutics.

Portfolio Pulse from Avi Kapoor

April 16, 2024 | 6:17 pm

ISRG

Deep-pocketed investors have shown a bearish sentiment towards Intuitive Surgical (NASDAQ:ISRG), with a significant move in options trading. Benzinga's tracking revealed 24 unusual options activities, with a bearish majority. The targeted price range for ISRG is between $300.0 and $430.0. Notable options activity includes both bullish and bearish sentiments, with a mix of puts and calls. Intuitive Surgical's current market status shows a slight price increase and a neutral RSI, with earnings expected in 2 days. Analysts from Stifel and Citigroup maintain Buy ratings with target prices of $430 and $462, respectively.

Portfolio Pulse from Benzinga Insights

April 16, 2024 | 6:16 pm

CURLF

MSOS

Boris Jordan, associated with Curaleaf, comments on unexpected real growth in the third quarter, already evident in the first two weeks. He highlights Germany as a bigger market than Florida, emphasizing Curaleaf's strong brand positioning in the cannabis industry.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 6:15 pm

JD

Benchmark analyst Fawne Jiang maintains a Buy rating on JD.Com, Inc (NASDAQ:JD) with a price target of $55, citing disciplined cost management and healthy GMV growth. The first quarter revenue projection remains unchanged at +6% y/y, with a raised non-GAAP NPM estimate to 2.8%. For FY24, GMV and revenue are expected to grow above China's retail growth rate with a stable profit year over year. The current estimates do not factor in potential stimulus policies from China's government, which could provide an upside to JD's stock.

Portfolio Pulse from Nabaparna Bhattacharya

April 16, 2024 | 6:10 pm

UNH

UnitedHealth Group (NYSE:UNH) reported Q1 earnings with better-than-expected revenue and earnings, despite a cyberattack on its subsidiary Change Healthcare. Adjusted EPS was $6.91, up from $6.26 a year ago, with revenues increasing to $99.8 billion. The company maintained its adjusted EPS guidance of $27.50-$28.00. Goldman Sachs reaffirmed a Buy rating on UNH with a price target of $593, citing a positive medical cost update and prudent outlook. UNH shares rose 5.10% to $468.35.

Portfolio Pulse from Vandana Singh

April 16, 2024 | 6:03 pm

XNCR

Analysts have updated their ratings on Xencor (NASDAQ:XNCR), with 6 recent ratings ranging from bullish to indifferent. The average 12-month price target is now $35.33, down from $45.20, reflecting a 21.84% decline. Analyst actions include lowering price targets and maintaining ratings, indicating a cautious but not entirely bearish outlook on the company. Xencor, a clinical-stage biopharmaceutical company, has shown significant revenue growth and strong financial performance indicators such as net margin and ROE.

Portfolio Pulse from Benzinga Insights

April 16, 2024 | 6:02 pm